Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Capital Expenditures (2017 - 2024)

Historic Capital Expenditures for MedWellAI (MWAI) over the last 8 years, with Q3 2024 value amounting to $2242.0.

  • MedWellAI's Capital Expenditures fell 9389.93% to $2242.0 in Q3 2024 from the same period last year, while for Jun 2025 it was $2242.0, marking a year-over-year change of. This contributed to the annual value of $2242.0 for FY2025, which is N/A changed from last year.
  • MedWellAI's Capital Expenditures amounted to $2242.0 in Q3 2024, which was down 9389.93% from -$1740.0 recorded in Q2 2024.
  • MedWellAI's Capital Expenditures' 5-year high stood at $2.4 million during Q2 2023, with a 5-year trough of -$35010.0 in Q4 2023.
  • For the 5-year period, MedWellAI's Capital Expenditures averaged around $443095.2, with its median value being $36750.0 (2023).
  • In the last 5 years, MedWellAI's Capital Expenditures skyrocketed by 1091632.99% in 2021 and then crashed by 10007.29% in 2024.
  • Over the past 5 years, MedWellAI's Capital Expenditures (Quarter) stood at $171605.0 in 2020, then tumbled by 96.05% to $6782.0 in 2021, then soared by 563.52% to $45000.0 in 2022, then tumbled by 177.8% to -$35010.0 in 2023, then soared by 106.4% to $2242.0 in 2024.
  • Its Capital Expenditures stands at $2242.0 for Q3 2024, versus -$1740.0 for Q2 2024 and -$35010.0 for Q4 2023.